$1.19
3M Ago | 1M Ago | Current | |
Buy | 7 | 6 | 7 |
Outperform | 7 | 7 | 7 |
Hold | 1 | 1 | 1 |
Underperform | 0 | 0 | 0 |
Sell | 0 | 0 | 0 |
The latest share price target for Aclaris Therapeutics Inc (ACRS) is $1.84, offered by 15 analysts offering 12-month price forecasts.
Aclaris Therapeutics Inc (ACRS) has a maximum of 0.55 upside potential, based on 15 analysts offering 12-month price forecasts.
Based on 15 analysts tracking and researching Aclaris Therapeutics Inc (ACRS), 93.33% have a buy recommendation. Remaining 6.67% have either sell or hold recommendations.
The latest share price of Aclaris Therapeutics Inc (ACRS) is $1.19 as of 22/05/2024.
14 of total 15 analysts offering stock ratings for Aclaris Therapeutics Inc ACRS have recommended buy rating.